1. Home
  2. INTC vs AZN Comparison

INTC vs AZN Comparison

Compare INTC & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intel Corporation

INTC

Intel Corporation

HOLD

Current Price

$129.79

Market Cap

566.5B

Sector

Technology

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$183.51

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTC
AZN
Founded
1968
1992
Country
United States
United Kingdom
Employees
N/A
96100
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
566.5B
316.4B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
INTC
AZN
Price
$129.79
$183.51
Analyst Decision
Hold
Strong Buy
Analyst Count
34
1
Target Price
$63.38
N/A
AVG Volume (30 Days)
112.0M
1.9M
Earning Date
04-23-2026
04-29-2026
Dividend Yield
N/A
1.73%
EPS Growth
98.63
N/A
EPS
N/A
N/A
Revenue
$52,853,000,000.00
N/A
Revenue This Year
$4.59
$10.34
Revenue Next Year
$7.73
$6.43
P/E Ratio
N/A
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$18.97
$68.62
52 Week High
$141.45
$212.71

Technical Indicators

Market Signals
Indicator
INTC
AZN
Relative Strength Index (RSI) 59.27 52.54
Support Level $38.67 $180.98
Resistance Level N/A $191.50
Average True Range (ATR) 8.29 2.97
MACD 1.14 0.41
Stochastic Oscillator 74.87 78.90

Price Performance

Historical Comparison
INTC
AZN

About INTC Intel Corporation

Intel is a leading digital chipmaker focused on designing and manufacturing microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors and led the semiconductor industry down the path of Moore's law for advances in semiconductor manufacturing. Intel remains the market share leader in central processing units in both the PC and server end markets. The company is seeking to reinvigorate its chip manufacturing business, Intel Foundry, while developing leading-edge products in its Intel Products business segment.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: